vs

Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and SAUL CENTERS, INC. (BFS). Click either name above to swap in a different company.

ANAPTYSBIO, INC is the larger business by last-quarter revenue ($108.2M vs $75.1M, roughly 1.4× SAUL CENTERS, INC.). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs 8.7%, a 37.2% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs 10.6%). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs 6.2%).

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.

Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.

ANAB vs BFS — Head-to-Head

Bigger by revenue
ANAB
ANAB
1.4× larger
ANAB
$108.2M
$75.1M
BFS
Growing faster (revenue YoY)
ANAB
ANAB
+140.4% gap
ANAB
151.1%
10.6%
BFS
Higher net margin
ANAB
ANAB
37.2% more per $
ANAB
45.8%
8.7%
BFS
Faster 2-yr revenue CAGR
ANAB
ANAB
Annualised
ANAB
288.3%
6.2%
BFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ANAB
ANAB
BFS
BFS
Revenue
$108.2M
$75.1M
Net Profit
$49.6M
$6.5M
Gross Margin
Operating Margin
61.8%
65.4%
Net Margin
45.8%
8.7%
Revenue YoY
151.1%
10.6%
Net Profit YoY
327.8%
-19.6%
EPS (diluted)
$1.64
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANAB
ANAB
BFS
BFS
Q4 25
$108.2M
$75.1M
Q3 25
$76.3M
$72.0M
Q2 25
$22.3M
$70.8M
Q1 25
$27.8M
$71.9M
Q4 24
$43.1M
$67.9M
Q3 24
$30.0M
$67.3M
Q2 24
$11.0M
$66.9M
Q1 24
$7.2M
$66.7M
Net Profit
ANAB
ANAB
BFS
BFS
Q4 25
$49.6M
$6.5M
Q3 25
$15.1M
$10.5M
Q2 25
$-38.6M
$10.7M
Q1 25
$-39.3M
$9.8M
Q4 24
$-21.8M
$8.1M
Q3 24
$-32.9M
$14.5M
Q2 24
$-46.7M
$14.4M
Q1 24
$-43.9M
$13.6M
Gross Margin
ANAB
ANAB
BFS
BFS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
73.6%
Q2 24
74.2%
Q1 24
72.8%
Operating Margin
ANAB
ANAB
BFS
BFS
Q4 25
61.8%
65.4%
Q3 25
45.5%
69.1%
Q2 25
-117.5%
68.7%
Q1 25
-99.2%
66.5%
Q4 24
-22.4%
82.9%
Q3 24
-75.8%
72.8%
Q2 24
-367.5%
75.0%
Q1 24
-587.8%
72.4%
Net Margin
ANAB
ANAB
BFS
BFS
Q4 25
45.8%
8.7%
Q3 25
19.8%
14.6%
Q2 25
-173.5%
15.1%
Q1 25
-141.6%
13.6%
Q4 24
-50.5%
11.9%
Q3 24
-109.4%
21.5%
Q2 24
-425.3%
21.6%
Q1 24
-612.0%
20.4%
EPS (diluted)
ANAB
ANAB
BFS
BFS
Q4 25
$1.64
$0.15
Q3 25
$0.52
$0.32
Q2 25
$-1.34
$0.33
Q1 25
$-1.28
$0.29
Q4 24
$-0.63
$0.22
Q3 24
$-1.14
$0.48
Q2 24
$-1.71
$0.48
Q1 24
$-1.64
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANAB
ANAB
BFS
BFS
Cash + ST InvestmentsLiquidity on hand
$238.2M
$8.7M
Total DebtLower is stronger
$468.4M
Stockholders' EquityBook value
$37.2M
$307.8M
Total Assets
$364.4M
$2.2B
Debt / EquityLower = less leverage
1.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANAB
ANAB
BFS
BFS
Q4 25
$238.2M
$8.7M
Q3 25
$109.8M
$11.8M
Q2 25
$44.3M
$5.3M
Q1 25
$98.6M
$6.5M
Q4 24
$123.1M
$10.3M
Q3 24
$191.6M
$7.2M
Q2 24
$71.8M
$6.9M
Q1 24
$53.7M
$7.1M
Total Debt
ANAB
ANAB
BFS
BFS
Q4 25
$468.4M
Q3 25
$1.6B
Q2 25
$1.6B
Q1 25
$1.5B
Q4 24
$455.8M
Q3 24
$1.5B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
ANAB
ANAB
BFS
BFS
Q4 25
$37.2M
$307.8M
Q3 25
$-29.4M
$316.6M
Q2 25
$-44.7M
$322.4M
Q1 25
$34.0M
$328.4M
Q4 24
$70.9M
$335.8M
Q3 24
$84.4M
$341.8M
Q2 24
$9.9M
$345.7M
Q1 24
$47.8M
$347.1M
Total Assets
ANAB
ANAB
BFS
BFS
Q4 25
$364.4M
$2.2B
Q3 25
$353.1M
$2.2B
Q2 25
$335.3M
$2.1B
Q1 25
$422.1M
$2.1B
Q4 24
$483.8M
$2.1B
Q3 24
$493.4M
$2.1B
Q2 24
$427.4M
$2.1B
Q1 24
$405.8M
$2.0B
Debt / Equity
ANAB
ANAB
BFS
BFS
Q4 25
1.52×
Q3 25
5.02×
Q2 25
4.85×
Q1 25
4.70×
Q4 24
1.36×
Q3 24
4.37×
Q2 24
4.17×
Q1 24
4.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANAB
ANAB
BFS
BFS
Operating Cash FlowLast quarter
$98.0M
$99.8M
Free Cash FlowOCF − Capex
$98.0M
FCF MarginFCF / Revenue
90.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.98×
15.35×
TTM Free Cash FlowTrailing 4 quarters
$19.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANAB
ANAB
BFS
BFS
Q4 25
$98.0M
$99.8M
Q3 25
$-27.4M
$20.6M
Q2 25
$-40.2M
$26.6M
Q1 25
$-10.7M
$30.4M
Q4 24
$-66.7M
$121.2M
Q3 24
$-10.1M
$26.5M
Q2 24
$-21.3M
$32.1M
Q1 24
$-37.3M
$33.8M
Free Cash Flow
ANAB
ANAB
BFS
BFS
Q4 25
$98.0M
Q3 25
$-27.4M
Q2 25
$-40.3M
Q1 25
$-10.7M
Q4 24
$-66.9M
Q3 24
$-10.1M
$-28.3M
Q2 24
$-21.4M
$-12.5M
Q1 24
$-37.3M
$-11.7M
FCF Margin
ANAB
ANAB
BFS
BFS
Q4 25
90.5%
Q3 25
-35.9%
Q2 25
-180.9%
Q1 25
-38.7%
Q4 24
-155.3%
Q3 24
-33.7%
-42.1%
Q2 24
-194.6%
-18.7%
Q1 24
-519.3%
-17.6%
Capex Intensity
ANAB
ANAB
BFS
BFS
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.2%
Q1 25
0.1%
Q4 24
0.6%
Q3 24
0.1%
81.5%
Q2 24
0.3%
66.7%
Q1 24
0.4%
68.3%
Cash Conversion
ANAB
ANAB
BFS
BFS
Q4 25
1.98×
15.35×
Q3 25
-1.81×
1.97×
Q2 25
2.48×
Q1 25
3.10×
Q4 24
14.98×
Q3 24
1.83×
Q2 24
2.22×
Q1 24
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons